Buch, Englisch, 330 Seiten, Format (B × H): 155 mm x 235 mm
Reihe: Research for Development
Integrating Multidisciplinary Perspectives in Design-Driven Pharma Practices
Buch, Englisch, 330 Seiten, Format (B × H): 155 mm x 235 mm
Reihe: Research for Development
ISBN: 978-3-031-53296-2
Verlag: Springer
This is an open access book.
This book provides a distinctive perspective on the daily utilization and consumption of medicines and drugs. It seamlessly integrates the research traditions of the medical and pharmaceutical realms with the approach of fostering the relationship between users and products, a characteristic of design and user studies. By applying a diverse range of expertise, the authors endeavor to reestablish the interconnectedness of issues that place the drug and the indispensable information for its use directly into the hands of the patient. The primary objective is to formulate an initial set of recommendations and compile a repertoire of best practices. Consequently, this book becomes an indispensable resource for students, professionals, and academics engaged in design culture, as well as those operating within the healthcare domain, such as the pharmaceutical industry, medical practitioners, and pharmacists. It is equally valuable for individuals working in institutions responsible for regulating medicines and overseeing their presence in the market. As a comprehensive guide, this book serves as an essential read, offering insights that bridge the gap between various sectors involved in the intricate landscape of medicine and drug consumption.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Technische Wissenschaften Maschinenbau | Werkstoffkunde Produktionstechnik
- Wirtschaftswissenschaften Betriebswirtschaft Bereichsspezifisches Management Betriebliches Gesundheitsmanagement
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizin, Gesundheit: Sachbuch, Ratgeber
Weitere Infos & Material
1 Towards in-home medication: Medicinal products as daily objects
Part 1 Objects of science: the pharmaceutical industry as a place of
preciseness
2 Medicine packaging legislation and its evolution according to technological innovation for better
healthcare support
Addendum 1 – Regulatory references
3 Primary medicine packaging and quality control
4 Pharmaceutical forms and primary packaging: a glossary
5 Secondary packaging of medicines: design processes for the pharmaceutical industry
6 Secondary packaging and leaflets: a glossary
Part 2- Prescribing and dispensing: accompanying the patient to the
correct use of medicines
7 Moving the care process in the in-home context: the therapeutic prescription
8 Dispensing medicines: A necessary link between doctor and patient
9 The future digital pharmacological prescription between therapy adherence and integrated healthcare personal plans
10 Navigating the complexities of the OTC medicine ecosystem
11 Dealing with medicines through online platforms and communities
Addendum 2 – Medication errors data
Part 3 - The daily life as a place of inaccuracy. the domesticity of
therapy
12 Medicines as designed objects
13 The in-home place of medications: perspectives of domestication
14 In-home. Medicinals treatment as a learning process
15 Use phenomenologies. Observing the user while taking pharmaceutical therapies
16 Use phenomenologies. Oral solid forms in blister packs
17 Use phenomenologies. What does the user do with the secondary medicine packaging and package leaflet?
Part 4 - The pharmaceutical product system: premises for the
definition of a repertory of good practices
18 How political and cultural challenges are impacting pharma industries
19 Medicinal products: when innovation meets the patient
20 Pharmaceutical packaging according to the “Packaging Ethics Charter”
21 Sensory qualities of the medicines: from problems to proposals
22 Compendium: step toward design-oriented practices in the pharma industry in a multidisciplinary perspective
Addendum 3 – The name of medicines. LASA medicines
Addendum 4 – Methods of user involvement
Addendum 5 – Error Reporting Procedures




